BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16630408)

  • 1. DHEA-induced antiproliferative effect in MCF-7 cells is androgen- and estrogen receptor-independent.
    Gayosso V; Montano LF; López-Marure R
    Cancer J; 2006; 12(2):160-5. PubMed ID: 16630408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line.
    Boccuzzi G; Di Monaco M; Brignardello E; Leonardi L; Gatto V; Pizzini A; Gallo M
    Anticancer Res; 1993; 13(6A):2267-72. PubMed ID: 8297144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
    Girón RA; Montaño LF; Escobar ML; López-Marure R
    FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
    Poulin R; Labrie F
    Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.
    Schmitt M; Klinga K; Schnarr B; Morfin R; Mayer D
    Mol Cell Endocrinol; 2001 Feb; 173(1-2):1-13. PubMed ID: 11223173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.
    Campelo AE; Cutini PH; Massheimer VL
    Steroids; 2012 Sep; 77(11):1033-40. PubMed ID: 22728893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol.
    Boccuzzi G; Brignardello E; di Monaco M; Forte C; Leonardi L; Pizzini A
    Anticancer Res; 1992; 12(3):799-803. PubMed ID: 1535770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor.
    Wang L; Wang YD; Wang WJ; Zhu Y; Li DJ
    J Mol Endocrinol; 2007 Apr; 38(4):467-79. PubMed ID: 17446236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
    Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D
    Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens.
    Tanaka Y; Kuwabara K; Okazaki T; Fujita T; Oizumi I; Kaiho S; Ogata E
    Oncology; 2000; 59 Suppl 1():19-23. PubMed ID: 11096352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line).
    Holinka CF; Hata H; Kuramoto H; Gurpide E
    Cancer Res; 1986 Jun; 46(6):2771-4. PubMed ID: 2938730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.
    Damien E; Price JS; Lanyon LE
    J Bone Miner Res; 2000 Nov; 15(11):2169-77. PubMed ID: 11092397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dehydroepiandrosterone and flutamide on hippocampal CA1 spine synapse density in male and female rats: implications for the role of androgens in maintenance of hippocampal structure.
    MacLusky NJ; Hajszan T; Leranth C
    Endocrinology; 2004 Sep; 145(9):4154-61. PubMed ID: 15178643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone sulfate causes proliferation of estrogen receptor-positive breast cancer cells despite treatment with fulvestrant.
    Calhoun KE; Pommier RF; Muller P; Fletcher WS; Toth-Fejel S
    Arch Surg; 2003 Aug; 138(8):879-83. PubMed ID: 12912747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors.
    Williams MR; Dawood T; Ling S; Dai A; Lew R; Myles K; Funder JW; Sudhir K; Komesaroff PA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4708-15. PubMed ID: 15356084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells.
    Lin HY; Sun M; Lin C; Tang HY; London D; Shih A; Davis FB; Davis PJ
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):182-8. PubMed ID: 19159686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells.
    López-Marure R; Contreras PG; Dillon JS
    Eur J Pharmacol; 2011 Jun; 660(2-3):268-74. PubMed ID: 21497598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.